+987.9%
MRNA vs PHM
+16.2%
+971.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PHM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +7.2% | +5.9% | +6.8% |
| 7D | +20.6% | +13.6% | +7.1% | +7.7% |
| 30D | +27.1% | +19.3% | +7.9% | +6.0% |
| 3M | +353.4% | +3.5% | +349.9% | +343.1% |
| 6M | +446.3% | +18.6% | +427.7% | +404.5% |
| YTD | +776.2% | +16.7% | +759.5% | +705.0% |
| 1Y | +987.9% | +14.6% | +973.3% | +887.9% |
| All | +987.9% | +16.2% | +971.7% | +887.9% |
Cumulative growth
Daily Returns
Daily percentage return beside PHM.
Daily Out/Under-Performance
Portfolio return minus PHM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PHM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PHM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling